(Q43993231)

28 November 2017

title

High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer. (English)

1 reference

28 November 2017

Kiyoshi Koshida

1

1 reference

28 November 2017

Hiroaki Kato

2

1 reference

28 November 2017

Atsushi Mizokami

3

1 reference

28 November 2017

Hiroshi Morishita

4

1 reference

28 November 2017

Chikashi Seto

5

1 reference

28 November 2017

Kazuto Komatsu

6

1 reference

28 November 2017

Eitetsu Kou

7

1 reference

28 November 2017

Tadao Uchibayashi

8

1 reference

28 November 2017

Shintaro Shiobara

9

1 reference

28 November 2017

Mikio Namiki

10

1 reference

28 November 2017

publication date

1 March 2002

1 reference

International Journal of Urology

28 November 2017

published in

1 reference

28 November 2017

volume

9

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

146-153

1 reference

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Salvage treatment in male patients with germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Prognosis after salvage treatment for unselected male patients with germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

High-dose chemotherapy in germ cell tumours: a large single centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.2002.00438.X

10.1046/J.1442-2042.2002.00438.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference